This inventor holds 4 USPTO granted patents. Top assignee: Auburn University. Active years: 2017-2025.
Company Filing History:
Years Active: 2017-2025
Title: Innovations by Alexander J Hodge
Introduction
Alexander J Hodge is an accomplished inventor based in Auburn, AL (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of stem cell research. With a total of 4 patents, Hodge's work focuses on the development of innovative methods for producing cell cultures and tissues.
Latest Patents
One of Hodge's latest patents is titled "Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels." This invention relates to the production of cell cultures and tissues from undifferentiated pluripotent stem cells using three-dimensional biomimetic materials. The resultant cell cultures or tissues can be utilized in various protocols, including testing chemicals, compounds, and drugs. Furthermore, the methods and compositions of this invention provide viable cell sources and novel cell delivery platforms that facilitate the replacement of diseased tissue and the engraftment of new cardiomyocytes from a readily available in vitro source. The patent includes novel methods required for the successful production of cell cultures and tissues, as well as systems and components used for the same.
Career Highlights
Hodge is affiliated with Auburn University, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
Some of Hodge's notable coworkers include Elizabeth A Lipke and Petra Kerscher. Their collaborative efforts contribute to the ongoing research and development in the field of stem cell technology.
Conclusion
Alexander J Hodge's innovative work in stem cell research and tissue engineering showcases his commitment to advancing medical science. His patents reflect a dedication to creating viable solutions for tissue replacement and regenerative therapies.